Incidence of respiratory infections and SARS-CoV-2 is higher during contact phases in student rugby players - Lessons learnt from COVID-19 risk mitigation strategies-AWARE V
Carolette Snyders, Nicola Sewry, Wayne Derman, Maaike Eken, Esme Jordaan, Sonja Swanevelder, Martin Schwellnus
Incidence of respiratory infections and SARS-CoV-2 is higher during contact phases in student rugby players - Lessons learnt from COVID-19 risk mitigation strategies-AWARE V
The incidence of acute respiratory infections (ARinf), including SARS-CoV-2, in unvaccinated student rugby players during phases from complete lockdown during the COVID-19 pandemic to returning to competition is unknown. The aim of the study was to determine the incidence of ARinf (including SARS-CoV-2) during non-contact and contact phases during the COVID-19 pandemic to evaluate risk mitigation strategies. In this retrospective cohort study, 319 top tier rugby players from 17 universities completed an online questionnaire. ARinf was reported during 4 phases over 14 months (April 2020-May 2021): phase 1 (individual training), phase 2 (non-contact team training), phase 3 (contact team training) and phase 4 (competition). Incidence (per 1 000 player days) and Incidence Ratio (IR) for ‘All ARinf’, and subgroups (SARS-CoV-2; ‘Other ARinf’) are reported. Selected factors associated with ARinf were also explored. The incidence of ‘All ARinf’ (0.31) was significantly higher for SARS-CoV-2 (0.23) vs. ‘Other ARinf’ (0.08) (p < 0.01). The incidence of ‘All ARinf’ (IR = 3.6; p < 0.01) and SARS-CoV-2 (IR = 4.2; p < 0.01) infection was significantly higher during contact (phases 3 + 4) compared with non-contact (phases 1 + 2). Demographics, level of sport, co-morbidities, allergies, influenza vaccination, injuries and lifestyle habits were not associated with ARinf incidence. In student rugby, contact phases are associated with a 3-4 times higher incidence of ARinf/SARS-CoV-2 compared to non-contact phases. Infection risk mitigation strategies in the contact sport setting are important. Data from this study serve as a platform to which future research on incidence of ARinf in athletes within contact team sports, can be compared.
COVID-19 / Athletes / Risk / Prevention / Epidemiology
[[1]] |
|
[[2]] |
|
[[3]] |
|
[[4]] |
|
[[5]] |
|
[[6]] |
|
[[7]] |
|
[[8]] |
World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA, 310 (20) ( 2013), pp. 2191-2194, DOI: 10.1001/jama.2013.281053
|
[[9]] |
|
[[10]] |
|
[[11]] |
Johns Hopkins University of Medicine. Number of daily cases. Johns Hopkins University of Medicine. Accessed January 17, 2024.
|
[[12]] |
|
[[13]] |
|
[[14]] |
|
[[15]] |
|
[[16]] |
|
[[17]] |
|
[[18]] |
|
[[19]] |
|
/
〈 | 〉 |